Title: Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspective
Abstract: HepatologyVolume 26, Issue 6 p. 1375-1379 Hepatology Concise ReviewFree Access Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspective V Agnello, V AgnelloSearch for more papers by this author V Agnello, V AgnelloSearch for more papers by this author First published: 30 December 2003 https://doi.org/10.1002/hep.510260642Citations: 45AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia: a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837– 856. 2 Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde M, Pietrogrande M, et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med 1995; 88: 115– 126. 3 Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490– 1495. 4 Levo Y, Gorevic PD, Kassab HJ, Zucher-Franklin D, Franklin EC. Associations between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977; 296: 1501. 5 Popp JW Jr, Dienstag JL, Wands JR, Bloch KJ. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 1980; 92: 379. 6 Kunkel HG, Agnello V, Joslin FG, Winchester RJ, Capra JD. Crossidiotypic specificity among monoclonal IgM proteins with Anti-y globulin activity. J Exp Med 1973; 137: 331– 342. 7 Gorevic PD, Frangione B. Mixed cryoglobulinemia cross-reactive idio-types: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991; 28: 79– 94. 8 Agnello V, Zhang QX, Abel G, Knight GB. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA crossidiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin Exp Rheum 1995; 13: 5101– 5104. 9 Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P, Gobbi M, et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen section Acta Haemotol 1988; 79: 20– 25. 10 Agnello V, ed. The immunopathology of hepatitis C virus infection. Springer Semin Immuopathol 1997; 19: 1– 131. 11 Cacoub P, Fabiani FL, Mussel L, Perrin M, Frangeul L, Leger JM, Huraux JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994; 96: 124– 132. 12 Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291– 1300. 13 Casato M, Agnello V, Pacific L, Knight GB, Leoni M, Del Vecchio S, Mazzilli C, et al. Analysis of longterm responders to interferon-a therapy in type II cryoglobulinemia secondary to hepatitis C virus infection. Blood 1997; 90: 3865– 3873. 14 Sansonno D, Cornacchiulo V, Lacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus–infected patients with mixed cryoglobulinemia. Hepatology 1995; 21: 305– 312. 15 Agnello V, Ábel G. Localization of hepatitis C virus in vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40: 2007– 2015. 16 Pucillo LP, Agnello V. Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from virus like particles in cryoprecipitate to viral localization in paramesangial deposits, problematic investigation prone to artifact. Curr Opin Nephrol Hyperten 1994; 3: 465– 470. 17 Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465– 470. 18 Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19: 111– 131. 19 Maggiore Q, Bartolomeo F, L'Abbate A, Misefari V, Martorano C, Caccamo A, di Beliojoso GB, et al. Glomerular localization of circulating antiglobulin activity in essential mixed cryoglobulinemia with glomerulonephritis. Kidney Int 1982; 21: 387– 394. 20 Sansonmo D, Gesualdo L, Manno C, Schema FP, Darmmaco F. Hepatitis C virus–related proteins in kidney tissue from hepatitis C virus–infected patients with cryoglobulinemia membranoproliferative glomerulonephritis. Hepatology 1997; 25: 1237– 1244. 21 Agnello V, Abel G, Knight GB, Zhang QX, Elfahal M, Confalonieri R, Montoli A, et al. The role of hepatitis C virus in the pathogenesis of type II cryoglobulinemia. Hepatitis C and Beyond. Keystone Symposia, Burlington, VT. 1995: 8, abstract 007. 22 Gorevic PD, Kassab JH, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287– 308. 23 Monterverde A, Ballaré M, Pilevi S. Hepatitic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997; 19: 99– 110. 24 Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JYN. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158: 1473– 1481. 25 Agnello V, Abel G, Knight GB, Monteverde A, Ballare M, Bertoncelli MC, Pileri SA. Detection of hepatitis C virus in liver, bone marrow, and lymph nodes in type II mixed cryoglobulinemia using in situ hybridization. 3rd International Meeting on Hepatitis C Virus and Related Virus, Gold Coast, Australia, 1995, abstract C163. 26 Monteverde A, Sabattini E, Poggi S, Ballare M, Bertoncelli MC, De Vivo A, Briskomatis A, et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma 1995; 2: 1119– 1124. 27 Galli M, Zehender G, Monti G, Ballare M, Saccardo F, Piconi S, De Maddelena C, et al. Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryo-globulinemic chronic hepatitis type C. Infect Dis 1995; 171: 672– 675. 28 Misiani R, Bellavita P, Fenili D, Marchesi D, Massazza M, Vendramin G, Comotti B, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573– 577. 29 Vilcek J, Sen GC. Interferons and other cytokines. In: BN Fields, DM Knipe, PM Howley, eds. Virology, 3rd ed. Philadelphia: Lippincott-Raven, 1996: 375– 399. 30 Miescher PA, Huang YP, Izui S. Type II cryoglobulinemia. Semin Hematol 1995; 32: 80– 85. 31 Invernizzo F. Type II and type III mixed cryoglobulinemia, rheumatoid factors, hepatitis C. Semin Clin Immunol 1993; 6: 31– 37. 32 Crovatto M, Ceselli S, Mazzaro C, Modolo ML, Martelli J, Mazzi G, Pozzato G, et al. HCV genotypes and cryoglobulinemia. Clin Exp Rheu-matol 1995; 13: 579. 33 Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Yahia MB Ben, Andre C, Voisin MC, et al. Extrahepatic immunologic manifestation in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169. 34 Sinico RA, Ribero ML, Fornasteri A, Renoldi P, Zhou J, Fasola M, Portera G, et al. Hepatitis C virus genotype in patients with essential mixed cryoglobulinemia. Q J Med 1995; 88: 805. 35 Willems M, Sheng L, Roskams T, Ramdani B, Doutrelepont JM, Neven F, Durex P, et al. Hepatits C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome. J Med Virol 1994; 44: 266. 36 Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, Longombardo G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31. 37 Thomssen R, Bonk S, Propfec C, Heerman KH, Kochel HG, Uy A. Association of hepatitis C virus in human sera with beta lipoprotein. Med Microbiol Immunol 1992; 181: 293– 300. 38 Agnello V. Hypothesis: the etiology of mixed cryoglobulinemia associated with hepatitis C virus infection. Scand J Immunol 1995; 421: 179– 184. 39 Knight GB, Agnello V, Bonagura V, Barnes JL, Panka DJ, Zhang QX. Human rheumatoid factor cross idiotypes. IV. Studies on WA Xld positive IgM without rheumatoid factor activity provide evidence that the WA Xld is not unique to rheumatoid factors and is distinct from the 17.109 and G6 Xlds. J Exp Med 1993; 178: 1903– 1911. 40 Abrignani S. Immune responses throughout hepatitis C virus infection: HCV from the immune system point of view. Springer Semin Immunopathol 1997; 19: 47– 56. 41 Chang KM, Reherman B, Chisari FV. Immunopathology of hepatits C. Springer Semin Immunopathol 1997; 19: 57– 68. 42 Koziel MJ, Walke BD. Characteristics of the intrahepatic cytotoxic T lymphocyte responses in chronic hepatitis C virus infection. Springer Semin Immunopathol 1997; 19: 69– 84. 43 Walker CM. Comparative features of hepatitis C virus infection in humans and chimpanzees. Springer Semin Immunopathol 1997; 19: 85– 98. 44 Farci P, Bukh J, Purall RH. The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 1997; 19: 5– 26. 45 Lanford RE, Chavez D, Chisari FV, Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse PCR. J Virol 1995; 69: 8079. 46 Major ME, Feinston SM. The molecular virology of hepatitis C. Hepatology 1997; 25: 1527– 1538. 47 Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995; 108: 157. 48 Höhler T, Gerken G, Notghi A, Knolle P, Lubjuhn R, Taheri H, Schneider P, et al. MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol 1997; 27: 259– 264. 49 Strassburg CP, Obermayer-Straub P, Manns MP. Autoimmunity in hepatitis C and D virus infection. J Viral Hepat 1996; 3: 49– 59. 50 Agnello V, Liang TJ. Is hepatitis C virus a sialodacryoadenitis virus? Hepatology 1997; 26: 509– 510. 51 Nightingale SD, Pelley RP, Delaney NL, Bias WB, Hamburger MI, Fried LF, Stienberg AG. Inheritance of mixed cryoglobulinemia. Am J Hum Genet 1981; 33: 735. 52 Migliorini P, Bombardiere S, Castellani A, Ferrara GB. HLA anitgens in essential mixed cryoglobulinemia. Arthritis Rheum 1981; 24: 932. 53 Berliner S, Wienberger A, Zamir R, Hazaz B, Pinkhas J. Familial cryoglobulinemia and C4 deficiency. Scand J Rheumatol 1984; 13: 151. 54 Agnello V, Abel G, Zhang QX, Elfahal M. The etiology of mixed cryoglobulinemia: the role of LDL receptor and apolipoprotein E2. Arthritis Rheum 1996; 39: 5315. Citing Literature Volume26, Issue6December 1997Pages 1375-1379 ReferencesRelatedInformation